About Jiang Zhu
Jiang Zhu received his Ph.D. degree in Tsinghua University, Beijing, China in 2009. Then as an assistant director of instruments technology department in CapitalBio Corporation, Beijing, he developed the commercial instrument for automatic and high-throughput gene diagnosis. The instrument has been successfully used for genetic hearing-loss mutation detection to prevent pharmacologic ototoxic deafness. He is currently a postdoctoral researcher in university of California, Irvine. He has pioneered in developing optical coherence angiography and optical coherence elastography for clinical practices.